Please use this identifier to cite or link to this item:
https://hdl.handle.net/10356/180337
Title: | Concentration-driven evolution of adaptive artificial ion channels or nanopores with specific anticancer activities | Authors: | Chen, Zhiqing Xie, Xiaopan Jia, Chunyan Zhong, Qishuo Zhang, Qiuping Luo, Daoxin Cao, Yin Mu, Yuguang Ren, Changliang |
Keywords: | Medicine, Health and Life Sciences | Issue Date: | 2024 | Source: | Chen, Z., Xie, X., Jia, C., Zhong, Q., Zhang, Q., Luo, D., Cao, Y., Mu, Y. & Ren, C. (2024). Concentration-driven evolution of adaptive artificial ion channels or nanopores with specific anticancer activities. Angewandte Chemie (International Ed. in English), 63(17), e202318811-. https://dx.doi.org/10.1002/anie.202318811 | Journal: | Angewandte Chemie (International ed. in English) | Abstract: | In nature, ceramides are a class of sphingolipids possessing a unique ability to self-assemble into protein-permeable channels with intriguing concentration-dependent adaptive channel cavities. However, within the realm of artificial ion channels, this interesting phenomenon is scarcely represented. Herein, we report on a novel class of adaptive artificial channels, Pn-TPPs, based on PEGylated cholic acids bearing triphenylphosphonium (TPP) groups as anion binding motifs. Interestingly, the molecules self-assemble into chloride ion channels at low concentrations while transforming into small molecule-permeable nanopores at high concentrations. Moreover, the TPP groups endow the molecules with mitochondria-targeting properties, enabling them to selectively drill holes on the mitochondrial membrane of cancer cells and subsequently trigger the caspase 9 apoptotic pathway. The anticancer efficacies of Pn-TPPs correlate with their abilities to form nanopores. Significantly, the most active ensembles formed by P5-TPP exhibits impressive anticancer activity against human liver cancer cells, with an IC50 value of 3.8 μM. While demonstrating similar anticancer performance to doxorubicin, P5-TPP exhibits a selectivity index surpassing that of doxorubicin by a factor of 16.8. | URI: | https://hdl.handle.net/10356/180337 | ISSN: | 1433-7851 | DOI: | 10.1002/anie.202318811 | Schools: | School of Biological Sciences | Rights: | © 2024 Wiley-VCH GmbH. All rights reserved. | Fulltext Permission: | none | Fulltext Availability: | No Fulltext |
Appears in Collections: | SBS Journal Articles |
SCOPUSTM
Citations
50
4
Updated on Nov 11, 2024
Page view(s)
33
Updated on Nov 11, 2024
Google ScholarTM
Check
Altmetric
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.